New Obesity Drugs Defy Logic – And Succeed – SciTechDaily

  1. New Obesity Drugs Defy Logic – And Succeed  SciTechDaily
  2. GIPR-Ab/GLP-1 peptide–antibody conjugate requires brain GIPR and GLP-1R for additive weight loss in obese mice  Nature
  3. GIP receptor shows surprising dual action: Both activation and blockade support weight loss  Medical Xpress

Source link

Leave a Comment